Neogen Statistics
Total Valuation
Neogen has a market cap or net worth of $2.07 billion. The enterprise value is $2.71 billion.
| Market Cap | 2.07B |
| Enterprise Value | 2.71B |
Important Dates
The next estimated earnings date is Tuesday, July 28, 2026, before market open.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Neogen has 217.67 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 217.67M |
| Shares Outstanding | 217.67M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 108.48% |
| Float | 216.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 35.22 |
| PS Ratio | 2.38 |
| Forward PS | 2.44 |
| PB Ratio | 0.98 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 342.22 |
| P/OCF Ratio | 29.81 |
| PEG Ratio | 3.52 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.29, with an EV/FCF ratio of 447.23.
| EV / Earnings | n/a |
| EV / Sales | 3.11 |
| EV / EBITDA | 33.29 |
| EV / EBIT | n/a |
| EV / FCF | 447.23 |
Financial Position
The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.38.
| Current Ratio | 3.92 |
| Quick Ratio | 1.97 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 9.02 |
| Debt / FCF | 131.44 |
| Interest Coverage | -0.57 |
Financial Efficiency
Return on equity (ROE) is -25.57% and return on invested capital (ROIC) is -1.31%.
| Return on Equity (ROE) | -25.57% |
| Return on Assets (ROA) | -0.61% |
| Return on Invested Capital (ROIC) | -1.31% |
| Return on Capital Employed (ROCE) | -1.12% |
| Weighted Average Cost of Capital (WACC) | 11.95% |
| Revenue Per Employee | $292,724 |
| Profits Per Employee | -$204,722 |
| Employee Count | 2,974 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 2.60 |
Taxes
| Income Tax | -19.27M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +78.42% in the last 52 weeks. The beta is 1.79, so Neogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.79 |
| 52-Week Price Change | +78.42% |
| 50-Day Moving Average | 9.07 |
| 200-Day Moving Average | 8.28 |
| Relative Strength Index (RSI) | 56.12 |
| Average Volume (20 Days) | 2,042,982 |
Short Selling Information
The latest short interest is 11.92 million, so 5.48% of the outstanding shares have been sold short.
| Short Interest | 11.92M |
| Short Previous Month | 13.03M |
| Short % of Shares Out | 5.48% |
| Short % of Float | 5.51% |
| Short Ratio (days to cover) | 4.55 |
Income Statement
In the last 12 months, Neogen had revenue of $870.56 million and -$608.84 million in losses. Loss per share was -$2.80.
| Revenue | 870.56M |
| Gross Profit | 393.58M |
| Operating Income | -35.92M |
| Pretax Income | -628.11M |
| Net Income | -608.84M |
| EBITDA | 81.26M |
| EBIT | -35.92M |
| Loss Per Share | -$2.80 |
Balance Sheet
The company has $159.90 million in cash and $795.10 million in debt, with a net cash position of -$635.20 million or -$2.92 per share.
| Cash & Cash Equivalents | 159.90M |
| Total Debt | 795.10M |
| Net Cash | -635.20M |
| Net Cash Per Share | -$2.92 |
| Equity (Book Value) | 2.10B |
| Book Value Per Share | 9.66 |
| Working Capital | 439.40M |
Cash Flow
In the last 12 months, operating cash flow was $69.44 million and capital expenditures -$63.40 million, giving a free cash flow of $6.05 million.
| Operating Cash Flow | 69.44M |
| Capital Expenditures | -63.40M |
| Depreciation & Amortization | 117.18M |
| Net Borrowing | -100.22M |
| Free Cash Flow | 6.05M |
| FCF Per Share | $0.03 |
Margins
Gross margin is 45.21%, with operating and profit margins of -4.13% and -69.94%.
| Gross Margin | 45.21% |
| Operating Margin | -4.13% |
| Pretax Margin | -72.15% |
| Profit Margin | -69.94% |
| EBITDA Margin | 9.33% |
| EBIT Margin | -4.13% |
| FCF Margin | 0.69% |
Dividends & Yields
Neogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.25% |
| Shareholder Yield | -0.25% |
| Earnings Yield | -29.41% |
| FCF Yield | 0.29% |
Analyst Forecast
The average price target for Neogen is $12.00, which is 26.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.00 |
| Price Target Difference | 26.18% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -1.96% |
| EPS Growth Forecast (3Y) | 8.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2021. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Neogen has an Altman Z-Score of 0.86 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.86 |
| Piotroski F-Score | 5 |